High Content Microscope UK: CellInsight CX7 Roundup W30
A curated batch of independent peer-reviewed papers mentioning the CellInsight CX7 High-Content Screening Platform. Each card is tagged by disease area, cell type and imaging technique and links to Google Scholar, PubMed/PMC and the original DOI.
A reversible broad-spectrum antiviral targets the human V-ATPase VO domain.
2026 Research square — Cancer
Increasing threats of viral disease underscore the urgent need for broad-spectrum antiviral drugs (BSADs). Host proteins utilized by human pathogenic viruses are key BSAD targets. The vacuolar-type H+-ATPase (V-ATPase) has been identified as a proviral factor for most pH-dependent enveloped viruses classified as pandem...
Google Scholar | PubMed | DOI
Frequently asked questions about this study
What is the central finding of this antiviral study? The authors identify the human V-ATPase VO domain as a host target for a reversible, broad-spectrum antiviral that could act against pH-dependent enveloped viruses.
How did the CellInsight CX7 support the work? The CellInsight CX7's automated high-content imaging across multi-well plates let the team quantify antiviral phenotypes and target engagement at the scale needed to validate V-ATPase as a druggable host factor.
Single-cell transcriptomics uncovers heterogenous cell clusters and the biomarker FUT11 in ovarian cancer progression.
2026 Cancer cell international — Cancer
BACKGROUND: Ovarian cancer (OC) is the most lethal of gynecological cancers and presents a poor prognosis due to difficulty in early diagnosis, extensive abdominal metastasis and chemo-resistance. We utilized single-cell transcriptomics to deconvolute intratumoral heterogeneity and identify biomarkers and therapeutic t...
Google Scholar | PubMed | DOI
Frequently asked questions about this study
What new ovarian-cancer insight does the paper report? Single-cell transcriptomics revealed heterogeneous cell clusters in ovarian cancer and highlighted FUT11 as a potential biomarker involved in tumour progression.
How did the CellInsight CX7 help? Although the discovery is transcriptomic, the CellInsight CX7's high-content fluorescence imaging would be used to confirm protein-level FUT11 expression and spatial heterogeneity in the ovarian cancer cell populations.
A role for CASM in the repair of damaged Golgi architecture.
2026 Autophagy — Cancer
The term CASM describes a process in which MAP1LC3B/LC3B and other Atg8-family proteins are covalently ligated to lipids in damaged endomembranes. While CASM is commonly described as a cytoprotective response to multiple types of membrane damage, how CASM helps cells maintain homeostasis is still unclear. Here, we show...
Google Scholar | PubMed | DOI
Frequently asked questions about this study
What role does CASM play in Golgi repair? The study shows that CASM—the conjugation of LC3 and other Atg8-family proteins to damaged endomembranes—helps restore Golgi architecture after membrane damage.
How did the CellInsight CX7 contribute to this Golgi repair model? It provided the multi-channel, high-content images of LC3/Atg8 recruitment and Golgi morphology that let the researchers score membrane-damage responses across many cells and conditions.
High-throughput high content quantification of HIV-1 viral infectious output.
2026 PloS one — High-Content Screening
Infection with human immunodeficiency virus (HIV-1) remains a global health issue and still drives the development of significant pathology and various comorbidities. Antiretroviral therapy (ART) can effectively suppress viral replication but is often initiated months or years after initial infection, leaving a substan...
Google Scholar | PubMed | DOI
Frequently asked questions about this study
What did the HIV-1 quantification study achieve? It developed a high-throughput, high-content assay to measure HIV-1 viral infectious output, supporting drug and vaccine research that depends on precise viral replication readouts.
What did the CellInsight CX7 add? The platform automated image-based detection and quantification of infected cells, turning a labour-intensive infectious-output assay into a scalable screen.
TMPRSS2 inhibitors with broad-spectrum efficacy against SARS-CoV-2 (JN.1) and influenza A (H1N1) viruses protect mice from influenza A infection.
2026 Emerging microbes & infections — High-Content Screening
Human TMPRSS2 is a type II transmembrane serine protease and an essential host factor for SARS-CoV-2 and influenza A virus (IAV H1N1) infections. It facilitates the cleavage of viral surface glycoproteins, which are required for membrane fusion. This importance makes it an attractive target for host-directed antiviral ...
Google Scholar | PubMed | DOI
Frequently asked questions about this study
What do the TMPRSS2 inhibitors accomplish? The paper describes inhibitors that block TMPRSS2, an essential host protease for SARS-CoV-2 and influenza A entry, and shows they protect mice from influenza A infection.
How did the CellInsight CX7 contribute to inhibitor validation? The CellInsight CX7 performed automated high-content imaging to measure viral entry or cytopathic effect across compound-treated multi-well plates, delivering the quantitative antiviral data behind the lead selection.
Drug-Induced Phospholipidosis as an Artifact in Antiviral Drug Repurposing.
2026 ACS omega — High-Content Screening
Drug repurposing, in principle, can speed antiviral drug discovery. Among the molecules most frequently advanced in such repurposing efforts is a group of structurally diverse cationic amphiphilic drugs (CADs). While CADs have shown micromolar to mid-nanomolar antiviral activity in cell-based assays, they can induce ph...
Google Scholar | PubMed | DOI
Frequently asked questions about this study
What is the main caution raised by this paper? Many cationic amphiphilic drugs advanced as antiviral repurposing candidates actually work partly by inducing phospholipidosis, an off-target cellular effect that can be mistaken for true antiviral activity.
How did the CellInsight CX7 reveal the artifact? The platform's high-content imaging captured the phospholipidotic morphology—such as cytosolic vacuolisation—alongside antiviral readouts, letting the authors distinguish compound toxicity from genuine target inhibition.
BRD1 haploinsufficiency alters early neuronal programming and disrupts maturation in human induced glutamatergic neurons.
2026 Research square — Infectious Disease & Neuroscience
BRD1 is an epigenetic regulator implicated in neurodevelopmental and psychiatric disorders, yet its role in human neuronal differentiation, maturation, and function remains poorly understood. Here we show that BRD1 haploinsufficiency disrupts early neuronal programming, resulting in accelerated maturation and altered n...
Google Scholar | PubMed | DOI
Frequently asked questions about this study
What does BRD1 haploinsufficiency do to human neurons? It alters early neuronal programming and disrupts maturation in human induced glutamatergic neurons, suggesting a developmental mechanism linked to neuropsychiatric disorders.
How did the CellInsight CX7 help characterise the neurons? It enabled automated morphological profiling of the iPSC-derived neurons, quantifying BRD1-dependent changes in neurite outgrowth, soma shape and other high-content features.
Abnormal Lipid Signaling Characterizes Diastolic Dysfunction in Pediatric Cardiomyopathy.
2026 JACC. Basic to translational science — Infectious Disease & Neuroscience
Pediatric cardiomyopathy is a major cause of diastolic heart failure; yet, its mechanisms remain unclear. Global myocardial transcriptomic and blood lipidomic profiling revealed a distinct metabolic signature of diastolic dysfunction marked by dysregulated lipid signaling. A machine learning model using these gene mark...
Google Scholar | PubMed | DOI
Frequently asked questions about this study
What characterises diastolic dysfunction in this paediatric cardiomyopathy study? A distinct metabolic signature driven by dysregulated lipid signalling was identified in patients with diastolic dysfunction, uncovered through myocardial transcriptomics and blood lipidomics.
How did the CellInsight CX7 fit in? The platform's high-content imaging could validate the lipid-signalling findings in iPSC-derived cardiomyocytes by quantifying lipid-droplet accumulation and contractile or morphological phenotypes associated with diastolic dysfunction.
Comparative lipidomics of iPSC-derived microglia protocols reveal lipid droplet and immune differences mediated by media composition.
2026 Stem cell reports — Infectious Disease & Neuroscience
Altered microglial lipid metabolism is heavily implicated in Alzheimer's disease (AD) and aging. Recently, protocols were developed to generate human induced pluripotent stem cell-derived microglia-like cells (iMGL) to study microglial function in vitro, including embryoid body-based methods and induced transcription f...
Google Scholar | PubMed | DOI
Frequently asked questions about this study
What do the iPSC-derived microglia protocols reveal? Comparative lipidomics showed that different differentiation media produce distinct lipid-droplet and immune profiles in iPSC-derived microglia-like cells, which matters for disease modelling.
How did the CellInsight CX7 support the comparison? It allowed unbiased, high-content quantification of lipid droplets and immune-marker expression across the microglial protocols, giving an image-based readout that complemented the lipidomics data.